Search

Progyny Inc

Fechado

SetorSaúde

26.62 1.33

Visão Geral

Variação de preço das ações

24h

Atual

Mín

25.58

Máximo

26.59

Indicadores-chave

By Trading Economics

Rendimento

28M

52M

Vendas

22M

351M

P/E

Médio do Setor

27.815

56.659

EPS

0.34

Margem de lucro

14.917

Funcionários

835

EBITDA

5.9M

44M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+33.67% upside

Dividendos

By Acuity

Próximos Ganhos

5 de nov. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-475M

2B

Abertura anterior

25.29

Fecho anterior

26.62

Sentimento de Notícias

By Acuity

88%

12%

319 / 340 Ranking em Healthcare

Progyny Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

2 de set. de 2026, 20:08 UTC

Progyny Inc shares are higher today, continuing gains since Tuesday's close. The stock peaked earlier in the session before settling back.

1 de set. de 2026, 23:41 UTC

Progyny Inc shares are higher in after-market hours, though no specific news was identified. The stock remains near its one-month range's lower end.

31 de ago. de 2026, 20:07 UTC

Progyny Inc. shares are lower as market sentiment shifts amid expectations of further interest rate hikes following the Jackson Hole Economic Symposium.

26 de ago. de 2026, 20:08 UTC

Progyny Inc shares are higher during Wednesday's session, continuing a notable gain since Tuesday. The stock remains below its 20-day moving average.

25 de ago. de 2026, 19:36 UTC

News

Progyny Inc. shares are advancing after reporting Q2 revenue growth of 5.3% and projecting full-year revenue between $1.36 billion and $1.385 billion.

24 de ago. de 2026, 19:36 UTC

Progyny Inc shares are lower today, reversing from earlier gains amid market volatility linked to geopolitical tensions and US sanctions against Iran.

20 de ago. de 2026, 19:31 UTC

News

Wells Fargo initiated coverage on Progyny Inc with an Overweight rating and a $37.00 price target, contributing to the stock's rise during Thursday's session.

18 de ago. de 2026, 20:06 UTC

Progyny Inc. shares are higher today, reflecting steady gains during the session. The stock remains below its 20-day moving average.

17 de ago. de 2026, 20:01 UTC

News

Progyny Inc shares are lower following a negative market reaction to its second-quarter earnings and lowered full-year revenue guidance to $1.37 billion.

14 de ago. de 2026, 20:06 UTC

Progyny Inc shares are higher during Friday's session, despite a recent pullback from earlier highs. Broader market sentiment remains mixed amid declining U.S. retail sales.

13 de ago. de 2026, 21:31 UTC

Progyny Inc shares are higher in after-market trading, recovering from earlier losses. No specific news was identified to explain the price movement.

12 de ago. de 2026, 20:01 UTC

News

Progyny Inc shares are lower following a Barclays downgrade, which cut the price target to $30 from $34, citing performance concerns.

11 de ago. de 2026, 20:02 UTC

News

Progyny Inc's stock is declining after a disappointing revenue forecast, despite strong second-quarter results that exceeded analyst expectations.

7 de ago. de 2026, 20:02 UTC

News

Progyny Inc's shares are lower after a cautious Q3 sales outlook, despite reporting revenue of $350.5 million that exceeded analyst expectations.

6 de ago. de 2026, 23:02 UTC

News

Progyny Inc shares are lower in after-market trading following a revenue guidance cut to $1.36 billion to $1.39 billion, below previous estimates.

31 de jul. de 2026, 19:46 UTC

Progyny Inc shares are lower today amid broader market pressures and rising bond yields. No specific company news was identified to explain the decline.

30 de jul. de 2026, 21:02 UTC

Progyny Inc shares are lower in after-market hours, with no specific news identified for the decline. The stock is below its 20-day moving average.

29 de jul. de 2026, 18:55 UTC

Progyny Inc shares are higher today, reflecting notable strength in trading. The stock remains above its 20-day moving average.

28 de jul. de 2026, 17:41 UTC

News
Social Media

Progyny Inc shares are lower following a downgrade by Barclays, which noted slowing website traffic growth at fertility clinics. Price target raised to $34 from $27.

24 de jul. de 2026, 15:06 UTC

News

BTIG maintained its Buy rating on Progyny and raised the price target to $40. Shares are trading higher, remaining above the 20-day moving average.

22 de jul. de 2026, 20:01 UTC

News

Progyny Inc shares are lower despite the acceptance of benefits at Pinnacle Fertility New York, enhancing access to reproductive care for members.

20 de jul. de 2026, 17:16 UTC

Progyny Inc shares are higher today, maintaining a position near their one-month trading range. No specific news was identified to explain the movement.

Comparação entre Pares

Variação de preço

Progyny Inc Previsão

Preço-alvo

By TipRanks

33.67% parte superior

Previsão para 12 meses

Média 34.3 USD  33.67%

Máximo 40 USD

Mínimo 30 USD

Com base em 10 analistas de Wall Street que oferecem metas de preço de 12 meses para Progyny Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

10 ratings

8

Comprar

2

Manter

0

Vender

Sentimento

By Acuity

319 / 340 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Baixa

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Progyny Inc

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
help-icon Live chat